<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03530280</url>
  </required_header>
  <id_info>
    <org_study_id>pregabalin</org_study_id>
    <nct_id>NCT03530280</nct_id>
  </id_info>
  <brief_title>Effect of Pregabalin on Postoperative Analgesia</brief_title>
  <official_title>Effect of Pregabalin on Postoperative Analgesia After Arthroscopic Knee Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ankara Diskapi Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ankara Diskapi Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      knee arthroscopy under spinal anesthesia were included in this study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Anesthesiologists I or II scheduled to undergo knee arthroscopy under spinal anesthesia are
      included in this study. The first group is administered 300 mg oral pregabalin 1 hour before
      surgery. The second group is the control group; patients in this group are administered a
      placebo capsule 1 hour before surgery.The third group is administered a placebo capsule 1
      hour before surgery and postoperative adductor canal block is performed. All patients will be
      received postoperative a tramadol i.v. patient control analgesia device. At the end of 24
      hours, the total amount of tramadol consumed by the patient will be recorded from the patient
      control analgesia. NRS score, white fast track will be questioned.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2018</start_date>
  <completion_date type="Anticipated">December 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>11-point numerical rating scale (NRS)</measure>
    <time_frame>24 hours</time_frame>
    <description>11-point numerical rating scale for pain (0='no pain' and 10='worst pain possible pain') were explained.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>tramadol consumption</measure>
    <time_frame>24 hours</time_frame>
    <description>24 hours tramadol consumption will be recorded as milligrams</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">48</enrollment>
  <condition>Postoperative Pain After Knee Arthroscopy</condition>
  <arm_group>
    <arm_group_label>pregabalin (lyrica)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>pregabalin (lyrica) 300 mg preoperative 1 hour before</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>a placebo capsule 1 hour before surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>adductor channel block group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group will receive adductor channel block including 20 ml of 0.25% bupivacaine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>pregabalin (lyrica)</intervention_name>
    <description>preoperative pregabalin or postoperative adductor block will perform.</description>
    <arm_group_label>pregabalin (lyrica)</arm_group_label>
    <other_name>adductor canal block</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>PLacebo</intervention_name>
    <description>Placebo</description>
    <arm_group_label>placebo group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>adductor channel block including bupivacaine</intervention_name>
    <description>adductor channel block including 20 ml of 0.25% bupivacaine</description>
    <arm_group_label>adductor channel block group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients between the ages of 18 and 70 years

          -  American Society of Anesthesiologists I or II

          -  Scheduled to undergo knee arthroscopy

        Exclusion Criteria:

          -  allergic to any medicines

          -  History of drug or alcohol abuse,

          -  Opioids or sedative medications

          -  History of psychiatric conditions

          -  Pregnant or lactating women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>fatma kavak akelma</last_name>
    <phone>905327079113</phone>
    <email>fatmakavak@yahoo.com</email>
  </overall_contact>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 26, 2018</study_first_submitted>
  <study_first_submitted_qc>May 18, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 21, 2018</study_first_posted>
  <last_update_submitted>May 18, 2018</last_update_submitted>
  <last_update_submitted_qc>May 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ankara Diskapi Training and Research Hospital</investigator_affiliation>
    <investigator_full_name>Fatma Kavak Akelma</investigator_full_name>
    <investigator_title>specialist doctor</investigator_title>
  </responsible_party>
  <keyword>pregabalin</keyword>
  <keyword>adductor canal block</keyword>
  <keyword>postoperative pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Pregabalin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

